Effectiveness of donepezil on several cognitive functions in patients with Alzheiner's disease over 12 months;Eficacia del donepezilo sobre diversas funciones cognitivas durante 12 meses en pacientes con enfermedad de Alzheimer

Neurologia

Volumn 16, Issue 8, 2001, Pages 342-347

  Lopez Pousa S ^a   Vilalta Franch, J ^a   Garre Olmo, J ^a   Turon Estrada, A ^a   Lozano Gallego, M ^a   Hernandez Ferrandiz M ^a   Fajardo Tibau, C ^a   Cruz Reina, M M ^a  

^a HOSPITAL SANTA CATERINA   (Spain)

Author keywords

Alzheimer's disease; CAMCOG; Cognitive deterioration; Donepezil; Neuropsychology

Indexed keywords

DONEPEZIL;

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CALCULATION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; LANGUAGE; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; TREATMENT OUTCOME;

ACETYLCHOLINE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COHORT STUDIES; FEMALE; HUMANS; INDANS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PIPERIDINES; VERBAL BEHAVIOR;

EID: 0035160261     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Tratamiento de la enfermedad de Alzheimer: Fármacos inhibidores de la enzima acetilcolinesterasa
2. A 24-week, double blind, placebo -controlled trial of donepezil in patients with Alzheimer's disease
3. The effects of donepezil in Alzheimer's disease - Results from a multinational trial
4. Clinical global measures of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia. Drug guidelines
5. Valoración neuropsicológica de las demencias
6. A new rating scale for Alzheimer's disease
7. CAMDEX. A standarized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia
8. Early detection of Alzheimer's disease using the Cambridge cognitive examination
9. Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's disease assessment scale that broadens its scope. The Alzheimer's Disease Cooperative study
10. Donepezil for mild and moderate Alzheimer's disease
11. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
12. CAMDEX, validación de la adaptación española
13. Early detection of Alzheimer's disease using the Cambridge cognitive examination
14. Efectividad a los seis meses del donepezilo en el tratamiento del deterioro cognitivo en pacientes con demencia tipo Alzheimer
15. Age at onset of Alzheimer's disease: Relation to pattern of cognitive dysfunction and rate of decline
16. Educational level and neuropsychological heterogeneity in dementia of the Alzheimer type
17. Neuropsychological detection and characterization of preclinical Alzheimer's disease
18. Neuropshychological features of early Alzheimer's disease: Preclinical and clinical stages
19. Evolution of neuropatthology of Alzheimer's disease
20. Decline across different domains of cognitive function in normal ageing: Results of a longitudinal population-based study using CAMCOG
21. Age related differences in neural activity during memory encoding and retreival: A positron emission tomography study
22. Context-dependent, neural system-specific neurophysiological concomitants of ageing: Mapping PET cortelates during cognitive activation
23. Typical and atypical metabolic patterns in early Alzheimer's disease: 18F-FDG and high spatial resolution PET study
24. Changes in memory processing with age
25. Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy
26. Elegibility of Alzheimer's disease clinic patients for clinical trials
27. Clinical subgroups of Alzheimer's syndrome
28. Neuropsychological subgroups of dementia of the Alzheimer's type
29. CAMCOG: A concise neuropsychological test to assist dementia diagnosis: Socio-demographic determinants in an elderly population sample